Related Experiment Video
Updated: May 22, 2026
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
[Chronic hepatitis C and insulin resistance]
1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. chung50@dsmc.or.kr
Summary
Hepatitis C virus (HCV) infection and insulin resistance worsen liver disease, reduce treatment effectiveness, and increase type 2 diabetes risk. Lifestyle and drug strategies are needed for metabolic changes in chronic hepatitis C.
Area of Science:
- Hepatology and Endocrinology
- Virology and Metabolic Syndrome
Context:
- Insulin resistance frequently co-occurs with chronic liver diseases.
- The interplay between hepatitis C virus (HCV) infection and insulin resistance presents a significant and growing public health challenge.
- Understanding the clinical implications of this relationship is crucial due to potential synergistic effects on liver disease severity.
Purpose:
- To elucidate the clinical consequences of the association between HCV infection and insulin resistance.
- To highlight the impact on liver disease progression, antiviral treatment efficacy, and diabetes risk.
- To explore the effects of antidiabetic agents on HCV infection and hepatocellular carcinoma risk.
Summary:
- HCV infection combined with insulin resistance accelerates liver disease progression and diminishes response to antiviral therapies.
- This combination increases the risk of developing type 2 diabetes in susceptible individuals.
- HCV can induce hepatic steatosis, particularly genotype 3, though its clinical significance is debated; recent reports link insulin or sulfonylurea use to hepatocellular carcinoma.
Impact:
- Necessitates modified lifestyle interventions and pharmacological approaches for managing chronic hepatitis C patients with metabolic alterations.
- Informs clinical practice regarding patient monitoring and treatment strategies for co-infected individuals.
- Underscores the need for further research into the complex interactions between viral infections and metabolic disorders.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...